TENX Tenax Therapeutics, Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Position
Source
21:20
Sep 10
Sep 10
r/pennystocks
Long TENX on Cantor target and Schneeberger stake
The author highlights Cantor Fitzgerald reiterating an overweight rating and $35 price target on Tenax Therapeutics (TENX) while shares trade near $1.95 with a ~$73M market cap. The thesis is reinforced by bio investor Dr. Daniel Schneeberger's Adar1 Capital Management position totaling 6,524,151 shares and by clinical data from the Cantor Global Healthcare Conference presentation. The author cites oral levosimendan safety, treatment effect in the HELP study, a +26.3 m 6MWD effect in patients with baseline under 333 m, and a 49% NT-proBNP reduction versus placebo as supporting evidence.
TENX
Tenax Therapeutics, Inc.
Long
1ST
—
—
01:04
Aug 10
Aug 10
16:39
Aug 07
Aug 07
Clean post-COVID trial should vindicate Levo
Buy TENX ahead of the upcoming binary readout; prior trial failure was likely noise from COVID-era walk-test confounders (remote testing, missed visits, deconditioned patients), while the new trial uses clean in-person methodology that should allow Levo's measurable hemodynamic effect to show through.
TENX
Tenax Therapeutics, Inc.
Long
—
—
About TENX Investor Commentary
Across the available history and selected sources, Buzzberg tracks TENX (Tenax Therapeutics, Inc.) across 7 sources: 19 bullish vs 0 bearish calls from 7 authors. Historical directional balance: 36% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 53 total trade ideas tracked. Latest voices: u/Da1lyGa1ns, seedy19tron.